Basic Drug Info
Manufacturer:Merck & Co., Inc.
Other Info:

Please follow these instructions carefully when using TIMOPTIC Registered trademark of MERCK& CO., Inc.

Copyright © 2001 MERCK & CO., Inc.

All rights reserved.

Use TIMOPTIC as prescribed by your doctor.If you use other topically applied ophthalmic medications, they should be administered at least 10 minutes before or after TIMOPTIC.Wash hands before each use.Before using the medication for the first time, be sure the Safety Strip on the front of the bottle is unbroken.

A gap between the bottle and the cap is normal for an unopened bottle. Tear off the Safety Strip to break the seal. To open the bottle, unscrew the cap by turning as indicated by the arrows on the top of the cap.

Do not pull the cap directly up and away from the bottle.

Pulling the cap directly up will prevent your dispenser from operating properly. Tilt your head back and pull your lower eyelid down slightly to form a pocket between your eyelid and your eye. Invert the bottle, and press lightly with the thumb or index finger over the “Finger Push Area” (as shown) until a single drop is dispensed into the eye as directed by your doctor. DO NOT TOUCH YOUR EYE OR EYELID WITH THE DROPPER TIP.OPHTHALMIC MEDICATIONS, IF HANDLED IMPROPERLY, CAN BECOME CONTAMINATED BY COMMON BACTERIA KNOWN TO CAUSE EYE INFECTIONS. SERIOUS DAMAGE TO THE EYE AND SUBSEQUENT LOSS OF VISION MAY RESULT FROM USING CONTAMINATED OPHTHALMIC MEDICATIONS.

IF YOU THINK YOUR MEDICATION MAY BE CONTAMINATED, OR IF YOU DEVELOP AN EYE INFECTION, CONTACT YOUR DOCTOR IMMEDIATELY CONCERNING CONTINUED USE OF THIS BOTTLE.If drop dispensing is difficult after opening for the first time, replace the cap on the bottle and tighten (DO NOT OVERTIGHTEN) and then remove by turning the cap in the opposite direction as indicated by the arrows on the top of the cap.Repeat steps 6 & 7 with the other eye if instructed to do so by your doctor.Replace the cap by turning until it is firmly touching the bottle. The arrow on the left side of the cap must be aligned with the arrow on the left side of the bottle label for proper closure.

Do not overtighten or you may damage the bottle and cap.

The dispenser tip is designed to provide a single drop; therefore, do NOT enlarge the hole of the dispenser tip.After you have used all doses, there will be some TIMOPTIC left in the bottle.

You should not be concerned since an extra amount of TIMOPTIC has been added and you will get the full amount of TIMOPTIC that your doctor prescribed.

Do not attempt to remove excess medicine from the bottle.WARNING: Keep out of reach of children.If you have any questions about the use of TIMOPTIC, please consult your doctor.Issued September 20059391006Manuf.

for: MERCK & CO., Inc., Whitehouse Station, NJ 08889, USABy: Laboratories Merck Sharp & Dohme-Chibret63963 Clermont-Ferrand Cedex 9, France

Clinical Trials:

Indications and Usage
TIMOPTIC Ophthalmic Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Intraocular pressure disorder --

Ocular Hypertension -- A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.

Open Angle Glaucoma -- Glaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris.

TIMOPTIC is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease (see WARNINGS); (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure (see WARNINGS); (7) cardiogenic shock; or (8) hypersensitivity to any component of this product.
Asthma -- A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).

Heart failure -- inability of the heart to pump blood at an adequate rate to fill tissue metabolic requirements or the ability to do so only at an elevated filling pressure.

Cardiogenic shock -- Shock resulting from diminution of cardiac output in heart disease.

Hypersensitivity -- Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.

As with many topically applied ophthalmic drugs, this drug is absorbed systemically.The same adverse reactions found with systemic administration of beta-adrenergic blocking agents may occur with topical administration. For example, severe respiratory reactions and cardiac reactions, including death due to bronchospasm in patients with asthma, and rarely death in association with cardiac failure, have been reported following systemic or ophthalmic administration of timolol maleate (see CONTRAINDICATIONS).

This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor. It should not to be used for self-diagnosis or treatment.